Enzyme Inhibitors as Antimicrobial Agents

  • J. J. Burchall
Conference paper
Part of the Topics in Infectious Diseases book series (TIDIS, volume 1)


The majority of our useful chemotherapeutic agents are not the product of deliberate and rational design. Most new antimicrobial agents discovered during the last 30 years have been isolated from the growth medium of filamentous fungi and Actinomycetes. The search for new compounds has been largely empirical with the main effort directed toward further exploitation of the unique synthetic abilities of the organisms in the Penicillium and Streptomyces group. A major advance in the rational design of antimicrobials was made in 1959 when it was discovered that the growth medium of Penicillium could be manipulated so that the organism produced 6-aminopenicillanic acid rather than the entire penicillin molecule (Batchelor et al. 1959). This opportunity for partial synthesis of novel penicillins was exploited skillfully by pharmaceutical chemists and compounds appeared with a variety of useful new properties (acid stability, ß-lactamase resistance).


Antimicrobial Agent Enzyme Inhibitor Sodium Lauryl Sulfate Dihydrofolate Reductase Enzyme Binding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amyes, S.G.B., and J. T. Smith: R-factor trimethoprim resistance mechanism: an insusceptible target site. Biochem. Biophys. Research Commun 58, 412–418 (1974).CrossRefGoogle Scholar
  2. Batchelor, F. R., F. P. Doyle, J.H.C. Nayler, and G. N. Rolinson: Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations. Nature 183, 257–258 (1959).PubMedCrossRefGoogle Scholar
  3. Burchall, J., and G. Hitchings: Inhibitor binding analysis of dihydrofolate reductases from various species. Mol. Pharmacol. 1, 126–136 (1965).PubMedGoogle Scholar
  4. Burchall, J.: Mechanism of action of trimethoprim-sulfamethoxazole-II. J. of Infect. Dis. 128 supplement, S437–S441 (1973).Google Scholar
  5. Cleland, W. W.: Steady state kinetics in “The Enzymes, Kinetics and Mechanism.” Vol. II, 3rd edition, ed. by P. D. Boyer, 1–65 (1970).Google Scholar
  6. Griffith, T. W., C. Carroway, and F. R. Leach: Vitamin transport in Escherichia coli. Fed. Proc. 30, 363 abs. (1971).Google Scholar
  7. Hitchings, G. H., E. A. Falco, H. Vanderwerff, P. B. Russell, and G. B. Elion: Antagonists of nucleic acid derivatives VII. 2,4-diaminopyrimidines. J. Biol. Chem. 199, 43–56 (1952).PubMedGoogle Scholar
  8. Hitchings, G. H., and J. Burchall: Inhibition of folate biosynthesis and function as a basis for chemotherapy. Advances in Enzymology 27, 417–468, Interscience Publishers, Inc., New York, N. Y. (1965).Google Scholar
  9. Hitchings, G., J. J. Burchall, and R. Ferone: Comparative enzymology of dihydrofolate reductases as a basis for chemotherapy. III Internat. Pharmacol. Congress, Abstr. 113, Sao Paulo, Brazil, July 24–30 (1966a).Google Scholar
  10. Hitchings, G. H., J. J. Burchall, and R. Ferone: The comparative enzymology of dihydrofolate reductase and the design of chemotherapeutic agents. Symp. for Gen. Microbiol. 16, 294–300 (1966b).Google Scholar
  11. Iwashima, A., and Y. Nose: An Escherichia coli mutant resistant to 2-aminohydroxythiazole. J. Biochemistry 62, 537–542 (1967).Google Scholar
  12. Iwashima, A., A. Matsumura, and Y. Nose: Thiamine binding protein of Escherichia coli. J. Bact. 108, 1419–1421 (1971).PubMedGoogle Scholar
  13. Koch, A., and J. Burchall: Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media. App. Microbiol. 22, 812–817 (1971).Google Scholar
  14. Sköld, O., and A. Widh: A new dihydrofolate reductase with low trimethoprim sensitivity induced by an R factor mediating high resistance to trimethoprim. J. Biol. Chem. 249, 4324–4325 (1974).PubMedGoogle Scholar
  15. Taylor, R. T., S. A. Norell, and M. L. Hanna: Uptake of cyanocobalamin by Escherichia coli B: some characteristics and evidence for a binding protein. Arch. Biochem. Biophys. 148, 366–381 (1972).PubMedCrossRefGoogle Scholar
  16. Woods, D. D.: The relation of p-aminobenzoic acid to the mechanism of action of sulfanilamide. Brit. J. Exptl. Pathol. 21, 74–90 (1940).Google Scholar

Copyright information

© Springer-Verlag/Wien 1975

Authors and Affiliations

  • J. J. Burchall

There are no affiliations available

Personalised recommendations